Industry Verticals »

All Categories

Insights »

About TMR »

Genome Engineering Market

Genome Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global genome engineering market for the historical period 2017–2018 and forecast period 2019–2027, increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development are projected to drive the global genome engineering market during the forecast period
  • According to the report, the global genome engineering market was valued at US$ 3,685.4 Mn in 2018 and is anticipated to expand at a CAGR of 10.9% from 2019 to 2027

To know the scope of our report Get a Sample on Genome Engineering Market

Increased Funding In Genomic Research: Key Drivers

  • Synthetic biology received funding of US$ 430 Mn in the U.S. from 2005 to 2010, which was much higher than US$ 160 Mn in Europe during the same period. The U.K. contributed around US$ 30 Mn. About 4% and 2% funding in the U.S. and Europe, respectively, was spent to explore ethical, social, and legal implications (ELSI) of synthetic biology. Government initiatives are on par with private investments.
  •  More than $700 million was spent on synthetic biology research, by Department of Energy (DOE). While NIH awarded a grant of $40 million for the same.
  • Universities across the globe have provided significant funding for research in synthetic biology. For instance, in 2008, three Dutch universities — Delft University of Technology (Department of Bionanoscience), University of Groningen (Centre for Synthetic Biology), and the Eindhoven University of Technology (Institute for Complex Molecular Systems) — declared they would invest around USD $90 million in synthetic biology research for a period of 5 years to 10 years.
  • Application of genome engineering in animals has increased significantly in the past few years. Usage of this technology brings with it ethical issues that relate to animal welfare.

Get a glimpse of the in-depth analysis through our Report Brochure

Investment by Pharmaceutical Companies for Developing New Treatments Boost Market Growth

  • Pharmaceutical firms have realized the new trends of treating genetic diseases by gene editing technologies. They are collaborating with gene editing companies to develop treatment option.
  • In December 2015, Bayer and CRISPR Therapeutics AG formed a joint agreement, to develop new technology to cure blindness, blood disorders, and congenital heart disease.  Bayer would be utilizing the CRISPR-Cas9 gene editing technology and would use its protein-engineering technology for the same. Bayer will contribute a minimum of USD 300 million in R&D investments in this joint venture.
  •  In January 2015, Novartis formed a collaboration with Intellia and Caribou, which would help Novartis to use CRISPR genome editing technology to engineer chimeric antigen receptor (CAR) T cells and hematopoietic stem cells and also to discover and develop other medicine. This collaboration received an undisclosed amount from Novartis and USD $15 million from both Intellia and Caribou.

 Stringent Regulatory Framework to Hamper Market

  • There are various regulatory frameworks for genetically modifying plant genome. Process based regulatory frameworks consider the techniques used to create new crop plant varieties. The regulation is triggered when the plant is developed by using recombinant DNA technology. The definitions and guidelines for regulation was decided by the organizations such as the United Nations Food and Agricultural Organization and treaties such as the Cartagena protocol. The regulation is followed in Europe, Argentina, Brazil, and several other regions. The product based regulatory framework that prevails in the U.S. and Canada primarily focuses on the inherent risk of the final product, rather than the technology used to make it.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Genome engineering Market: Competitive Landscape

  • This report profiles major players in the global genome engineering market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The major players operating in the global genome engineering market are
    • Applied Stem Cell, Inc.
    • GenScript
    • Horizon Discovery Group plc
    • Integrated DNA Technologies, Inc.
    • Lonza Group Ltd.
    • New England Biolabs
    • OriGene Technologies, Inc.
    • Sangamo BioSciences, Inc.
    • Sigma-Aldrich Co. LLC.
    • Thermo Fisher Scientific, Inc.,
    • Transposagen Biopharmaceuticals, Inc.

Global Genome engineering Market: Key Developments

  • In January 2015,  four research collaborations with The Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, California, Thermo Fisher Scientific, Waltham, Massachusetts and Broad Institute/Whitehead Institute, Cambridge, Massachusetts to use CRISPR technology to identify and validate new drugs in preclinical models that would resemble human diseases.

The report on the global genome engineering market discussed individual strategies, followed by company profile of manufacturer of genome engineering. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global genome engineering market.

Global Genome engineering Market - Segmentation

Technology

Clustered regularly interspaced short palindromic repeats (CRISPR)

Transcription activator-like effector nuclease (Talen)

Zinc Finger Nuclease (ZFN)

Other Technologies

Application

Cell Line Engineering

Animal Genome Engineering

Plant Genome Engineering

Other Application

End-user

Pharmaceutical and Biotechnology Companies

Academics

Clinical Research Organizations

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of genome engineering market?

The global genome engineering market was worth US$ 3,685.4 Mn and is projected to reach a value of US$ 9,595.2 Mn by the end of 2027

What is the anticipated CAGR of genome engineering market in forecast period?

Genome engineering market is anticipated to grow at a CAGR of 10.9% during the forecast period

Which region is expected to project highest market share in genome engineering market?

North America accounted for a major share of the global genome engineering market

What are the key driving factors for growth of genome engineering market?

Genome engineering market is driven by increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development

Who are the key players in global genome engineering market?

Key players in the global genome engineering market include Applied Stem Cell, Inc., GenScript, Horizon Discovery Group plc, Integrated DNA Technologies, Inc., Lonza Group Ltd., New England Biolabs, OriGene Technologies, Inc., Sangamo BioSciences, Inc., Sigma-Aldrich Co. LLC., Thermo Fisher Scientific, Inc., and Transposagen Biopharmaceuticals, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Genome Engineering Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Genome Engineering Market Analysis and Forecasts, 2018–2030

    5. Key Insights

        5.1. Technological Advancements

        5.2. Healthcare Industry Overview

    6. Global Genome Engineering Market Analysis and Forecasts, By Technology 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value  Forecast By Technology, 2018–2030

            6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            6.3.2. Transcription activator-like effector nuclease (Talen) 

            6.3.3. Zinc Finger Nuclease (ZFN) 

            6.3.4. Others

        6.4. Market Attractiveness By Technology 

    7. Global Genome Engineering Market Analysis and Forecasts, By Application 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value  Forecast By Application, 2018–2030

            7.3.1. Cell Line Engineering 

            7.3.2. Animal Genome Engineering 

            7.3.3. Plant Genome Engineering 

            7.3.4. Others

        7.4. Market Attractiveness By Application 

    8. Global Genome Engineering Market Analysis and Forecasts, By End-user 

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value  Forecast By End-user, 2018–2030

            8.3.1. Pharmaceutical and Biotechnology Companies

            8.3.2. Academics

            8.3.3. Clinical Research Organizations

        8.4. Market Attractiveness By End-user 

    9. Global Genome Engineering Market Analysis and Forecasts, By Region

        9.1. Key Findings

        9.2. Market Value  Forecast By Region

            9.2.1. North America 

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. Market Attractiveness By Region

    10. North America Genome Engineering Market Analysis and Forecast

        10.1. Introduction

        10.2. Market Value  Forecast By Technology, 2018–2030

            10.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            10.2.2. Transcription activator-like effector nuclease (Talen) 

            10.2.3. Zinc Finger Nuclease (ZFN) 

            10.2.4. Others

        10.3. Market Value  Forecast By Application, 2018–2030

            10.3.1. Cell Line Engineering 

            10.3.2. Animal Genome Engineering 

            10.3.3. Plant Genome Engineering 

            10.3.4. Others

        10.4. Market Value  Forecast By End-user, 2018–2030

            10.4.1. Pharmaceutical and Biotechnology Companies

            10.4.2. Academics

            10.4.3. Clinical Research Organizations

        10.5. Market Value  Forecast By Country, 2018–2030

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis 

            10.6.1. By Technology 

            10.6.2. By Application 

            10.6.3. By End-user 

            10.6.4. By Country

    11. Europe Genome Engineering Market Analysis and Forecast

        11.1. Introduction

        11.2. Market Value  Forecast By Technology, 2018–2030

            11.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            11.2.2. Transcription activator-like effector nuclease (Talen) 

            11.2.3. Zinc Finger Nuclease (ZFN) 

            11.2.4. Others

        11.3. Market Value  Forecast By Application, 2018–2030

            11.3.1. Cell Line Engineering 

            11.3.2. Animal Genome Engineering 

            11.3.3. Plant Genome Engineering 

            11.3.4. Others

        11.4. Market Value  Forecast By End-user, 2018–2030

            11.4.1. Pharmaceutical and Biotechnology Companies

            11.4.2. Academics

            11.4.3. Clinical Research Organizations

        11.5. Market Value  Forecast By Country, 2018–2030

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis 

            11.6.1. By Technology 

            11.6.2. By Application 

            11.6.3. By End-user 

            11.6.4. By Country

    12. Asia Pacific Genome Engineering Market Analysis and Forecast

        12.1. Introduction

        12.2. Market Value  Forecast By Technology, 2018–2030

            12.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            12.2.2. Transcription activator-like effector nuclease (Talen) 

            12.2.3. Zinc Finger Nuclease (ZFN) 

            12.2.4. Others

        12.3. Market Value  Forecast By Application, 2018–2030

            12.3.1. Cell Line Engineering 

            12.3.2. Animal Genome Engineering 

            12.3.3. Plant Genome Engineering 

            12.3.4. Others

        12.4. Market Value  Forecast By End-user, 2018–2030

            12.4.1. Pharmaceutical and Biotechnology Companies

            12.4.2. Academics

            12.4.3. Clinical Research Organizations

        12.5. Market Value  Forecast By Country, 2018–2030

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis 

            12.6.1. By Technology 

            12.6.2. By Application 

            12.6.3. By End-user 

            12.6.4. By Country

    13. Latin America Genome Engineering Market Analysis and Forecast

        13.1. Introduction

        13.2. Market Value  Forecast By Technology, 2018–2030

            13.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            13.2.2. Transcription activator-like effector nuclease (Talen) 

            13.2.3. Zinc Finger Nuclease (ZFN) 

            13.2.4. Others

        13.3. Market Value  Forecast By Application, 2018–2030

            13.3.1. Cell Line Engineering 

            13.3.2. Animal Genome Engineering 

            13.3.3. Plant Genome Engineering 

            13.3.4. Others

        13.4. Market Value  Forecast By End-user, 2018–2030

            13.4.1. Pharmaceutical and Biotechnology Companies

            13.4.2. Academics

            13.4.3. Clinical Research Organizations

        13.5. Market Value  Forecast By Country, 2018–2030

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis 

            13.6.1. By Technology 

            13.6.2. By Application 

            13.6.3. By End-user 

            13.6.4. By Country

    14. Middle East & Africa Genome Engineering Market Analysis and Forecast

        14.1. Introduction

        14.2. Market Value  Forecast By Technology, 2018–2030

            14.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

            14.2.2. Transcription activator-like effector nuclease (Talen) 

            14.2.3. Zinc Finger Nuclease (ZFN) 

            14.2.4. Others

        14.3. Market Value  Forecast By Application, 2018–2030

            14.3.1. Cell Line Engineering 

            14.3.2. Animal Genome Engineering 

            14.3.3. Plant Genome Engineering 

            14.3.4. Others

        14.4. Market Value  Forecast By End-user, 2018–2030

            14.4.1. Pharmaceutical and Biotechnology Companies

            14.4.2. Academics

            14.4.3. Clinical Research Organizations

        14.5. Market Value  Forecast By Country, 2018–2030

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis 

            14.6.1. By Technology 

            14.6.2. By Application 

            14.6.3. By End-user 

            14.6.4. By Country

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (By Tier and Size of companies)

        15.2. Market Share Analysis By Company (2019)

        15.3. Company Profiles

            15.3.1. Applied Stem Cell, Inc.

            15.3.2. GenScript

            15.3.3. Horizon Discovery Group plc 

            15.3.4. Integrated DNA Technologies, Inc. 

            15.3.5. Lonza Group Ltd.

            15.3.6. New England Biolabs 

            15.3.7. OriGene Technologies, Inc.

            15.3.8. Sangamo BioSciences, Inc. 

            15.3.9. Sigma-Aldrich Co. LLC. 

            15.3.10. Thermo Fisher Scientific, Inc.

            15.3.11. Transposagen Biopharmaceuticals, Inc.

    List of Table

    Table 01 Genome engineering Market Size (US$ Mn) Forecast, By Technology, 2019–2027

    Table 02 Genome engineering Market Size (US$ Mn) Forecast, By Application, 2019–2027

    Table 03 Genome engineering Market Size (US$ Mn) Forecast, By End-user, 2019–2027

    Table 04 Genome engineering Market Size (US$ Mn) Forecast, By Geography, 2019–2027

    Table 05 North America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

    Table 06 North America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

    Table 07 North America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

    Table 08 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

    Table 09 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Application, 2019–2027

    Table 10 Europe Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

    Table 11 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

    Table 12 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

    Table 13 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

    Table 14 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

    Table 15 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

    Table 16 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

    Table 17 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

    Table 18 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

    Table 19 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

    List of Figure

    Figure 01 Genome engineering Market Snapshot

    Figure 02 Genome engineering Market Size (US$ Mn) and Forecast, 2019–2027

    Figure 03 Genome engineering Technology Market Revenue (US$ Mn) and Y-o-Y growth (%), 2019–2027

    Figure 04 Genome engineering Market Attractiveness Analysis By Technology

    Figure 05 Genome engineering Market Attractiveness Analysis By Application

    Figure 06 Genome engineering Market Attractiveness Analysis By End-user

    Figure 07 North America Genome engineering Value Share Analysis, By Technology, 2019 and 2027

    Figure 08 North America Genome engineering Value Share Analysis, By Application, 2019 and 2027

    Figure 09 North America Genome engineering Value Share Analysis, By End-user, 2019 and 2027

    Figure 10 Europe Genome engineering Value Share Analysis, By Technology, 2019 and 2027

    Figure 11 Europe Genome engineering Value Share Analysis, By Application, 2019 and 2027

    Figure 12 Europe Genome engineering Value Share Analysis, By End-user, 2019 and 2027

    Figure 13 Asia Pacific Genome engineering Value Share Analysis, By Technology, 2019 and 2027

    Figure 14 Asia Pacific Genome engineering Value Share Analysis, By Application, 2019 and 2027

    Figure 15 Asia Pacific Genome engineering Value Share Analysis, By End-user, 2019 and 2027

    Figure 16 Latin America Genome engineering Value Share Analysis, By Technology, 2019 and 2027

    Figure 17 Latin America Genome engineering Value Share Analysis, By Application, 2019 and 2027

    Figure 18 Latin America Genome engineering Value Share Analysis, By End-user, 2019 and 2027

    Figure 19 Middle East & Africa Genome engineering Value Share Analysis, By Technology, 2019 and 2027

    Figure 20 Middle East & Africa Genome engineering Value Share Analysis, By Application, 2019 and 2027

    Figure 21 Middle East & Africa Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Genome Engineering Market

Schedule a Call